Quarterly Transactions Made in T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX). The information is specifically focused on institutions that hold shares of TScan Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 0 | 8,847,313 | 8,847,313 | — | 8,847,313 | |||
| Q4 2021 | 66,052 | 1,564,718 | 1,630,770 | 259,253 | 309,114 | 568,367 | 1,062,403 | |
| Q1 2022 | 163,886 | 432,605 | 596,491 | 876,114 | 180,369 | 1,056,483 | -459,992 | |
| Q2 2022 | 1,946,503 | 280,485 | 2,226,988 | 9,702 | 1,864,882 | 1,874,584 | 352,404 | |
| Q3 2022 | 118,732 | 27,009 | 145,741 | 119,460 | 0 | 119,460 | 26,281 | |
| Q4 2022 | 42,782 | 132,186 | 174,968 | 258,208 | 0 | 258,208 | -83,240 | |
| Q1 2023 | 145,166 | 556,917 | 702,083 | 7,142 | 0 | 7,142 | 694,941 | |
| Q2 2023 | 5,180,185 | 13,728,899 | 18,909,084 | 341,581 | 0 | 341,581 | 18,567,503 | |
| Q3 2023 | 1,268,862 | 97,512 | 1,366,374 | 129,762 | 0 | 129,762 | 1,236,612 | |
| Q4 2023 | 353,704 | 3,055,249 | 3,408,953 | 152,500 | 0 | 152,500 | 3,256,453 | |
| Q1 2024 | 1,584,507 | 1,019,850 | 2,604,357 | 97,376 | 0 | 97,376 | 2,506,981 | |
| Q2 2024 | 5,204,011 | 9,019,360 | 14,223,371 | 1,305,117 | 0 | 1,305,117 | 12,918,254 | |
| Q3 2024 | 1,451,062 | 6,369,574 | 7,820,636 | 1,401,594 | 10,792 | 1,412,386 | 6,408,250 | |